Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers

American Journal of Pathology

Volumn 164, Issue 5, 2004, Pages 1727-1737

  Bao, Lere ^a   Kimzey, Amy ^a   Sauter, Guido ^c   Sowadski, Janusz M ^a   Lu, Kun Ping ^b   Wang, Da Gong ^a  

^a Pintex Pharmaceuticals   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ISOMERASE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROLINE; PROLYL ISOMERASE PIN1; SERINE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TUMOR; CANCER CELL; CARCINOGENESIS; CELL TYPE; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LUNG CANCER; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CANCER;

EID: 1942533406     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63731-5     Document Type: Article

References (35)

1. Blume-Jensen P, Hunter T: Oncogenic kinase signaling. Nature 2001, 411:355-365
2. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70
3. Lu KP, Liou YC, Zhou XZ: Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol 2002, 12:164-172
4. Lu KP, Hanes SD, Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547
5. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP: Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960
6. Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Küllertz G, Stark M, Fischer G, Lu KP: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 2000, 6:873-883
7. Ranganathan R, Lu KP, Hunter T, Noel JP: Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886
8. Shen M, Stukenberg PT, Kirschner MW, Lu KP: The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 1998, 12:706-720
9. Crenshaw DG, Yang J, Means AR, Kornbluth S: The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 1998, 17:1315-1327
10. Lu PJ, Zhou XZ, Shen M, Lu KP: A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328
11. Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP: The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788
12. Wu X, Wilcox CB, Devasahayam G, Hackett RL, Arevalo-Rodriguez M, Cardenas ME, Heitman J, Hanes SD: The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. EMBO J 2000, 19:3727-3738
13. Stukenberg PT, Kirschner MW: Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell 2001, 7:1071-1083
14. Hsu T, McRackan D, Vincent TS, Gert De Couet H: Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat Cell Biol 2001, 3:538-543
15. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Lu KP: Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 2001, 20:3459-3472
16. Ryo A, Nakamura N, Wulf G, Liou YC, Lu KP: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 2001, 3:793-801
17. Liou YC, Ryo R, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchidafl U, Hunter T, Lu KP: Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002, 99:1335-1340
18. Ryo A, Liou YC, Wulf G, Nakamura N, Lee SW, Lu KP: Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002, 22:5281-5295
19. Basu A, Das M, Qanungo S, Fan XJ, DuBois G, Haldar S: Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. Neoplasia 2002, 4:218-227
20. Basu A, Haldar S: Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway. Int J Oncol 2002, 21:597-601
21. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP: Regulation of NF-kappaB signaling by Pin1-catalyzed prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003, 12:1413-1426
22. Ayala G, Wang DG, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 2003, 63:6244-6251
23. Lu KP, Hunter T: Evidence for a NIMA-like mitotic pathway in vertebrate cells. Cell 1995, 81:413-424
24. Nocito A, Kononen J, Kallioniemi O, Sauter G: Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001, 94:1-5
25. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G: Tissue microarrays for rapid linking of molecular changes to clinical end-points. Am J Pathol 2001, 159:2249-2256
26. Sauter G, Simon R, Hillan K: Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003, 2:962-972
27. Lu PJ, Zhou XZ, Liou YC, Noel J, Lu KP: Critical role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function. J Biol Chem 2002, 277:2381-2384
28. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP: Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem 2002, 277:47976-47979
29. Weinberg RA: The molecular basis of oncogenes and tumor suppressor genes. Ann NY Acad Sci 1995, 758:331-338
30. Macleod K: pRb and E2f-1 in mouse development and tumorigenesis. Curr Opin Genet Dev 1999, 9:31-39
31. Nevins JR: The Rb/E2F pathway and cancer. Hum Mol Genet 2001, 10:699-703
32. Trimarchi JM, Lees JA: Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002, 3:11-20
33. Verdecia MA, Bowman ME, Lu KP, Hunter T, Noel JP: Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat Struct Biol 2000, 7:639-643
34. Rippmann JF, Hobbie S, Daiber C, Guilliard B, Bauer M, Birk J, Nar H, Garin-Chesa P, Rettig WJ, Schnapp A: Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 2000, 11:409-416
35. Fujimori F, Takahashi K, Uchida C, Uchida T: Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 1999, 265:658-663